Benjamin Edwards’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Other funds holding UTHR
Benjamin Edwards's UTHR Position: Q3 2026 in Review
Benjamin Edwards increased its United Therapeutics (UTHR) stake by 5.1% in Q3 2026, buying an estimated $12.4K and bringing the position to 497 shares worth $269K. The position accounts for ﹤0.01% of the portfolio, ranked #1295.
Benjamin Edwards first reported a position in UTHR in Q2 2026 and has held it in 2 quarters since. 673 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.
- Benjamin Edwards held 497 shares of United Therapeutics worth $269K as of Q3 2026.
- Benjamin Edwards bought 24 United Therapeutics shares in Q3 2026, an estimated $12.4K.
- United Therapeutics made up ﹤0.01% of Benjamin Edwards's portfolio in Q3 2026, its #1295 holding.
- Benjamin Edwards first reported a position in United Therapeutics in Q2 2026 and has held it in 2 quarters since.
- 673 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.
Based on Benjamin Edwards's 13F filing for Q3 2026, filed 12 Nov 2026.